MCL1 and acute myeloid leukemia: In primary AML patient samples, TG02 inhibited transcription by inducing RNA Pol II Ser2 dephosphorylation and downregulated MCL-1 and XIAP, leading to subsequent BAX activation and apoptosis [89].